{"id":986095,"date":"2026-07-28T18:10:54","date_gmt":"2026-07-28T22:10:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/"},"modified":"2026-07-28T18:10:54","modified_gmt":"2026-07-28T22:10:54","slug":"nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/","title":{"rendered":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN FRANCISCO<\/span>, July 28, 2026<\/span> \/PRNewswire\/ — Nektar\u00a0Therapeutics (Nasdaq:\u00a0NKTR) will announce its financial results for the second quarter ended June 30, 2026 on\u00a0Thursday, August 13, 2026, after the close of\u00a0U.S.-based financial markets.\u00a0Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at\u00a05:00 p.m. Eastern Time\/2:00 p.m. Pacific Time.<\/p>\n

\n

\n \"Nektar\n <\/p>\n<\/p><\/div>\n

This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar\u00a0website:\u00a0https:\/\/ir.nektar.com\/.<\/a>\u00a0The web broadcast of the conference call will be available for replay through\u00a0September 13, 2026.<\/p>\n

To\u00a0access\u00a0the\u00a0conference\u00a0call,\u00a0please\u00a0pre-register\u00a0here<\/a>. \u00a0All registrants will receive dial-in information and a PIN allowing them to access the live call.<\/p>\n

\n About<\/b>\u00a0Nektar Therapeutics<\/b><\/p>\n

Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar’s lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in a registrational program in atopic dermatitis, being planned for a registrational program in alopecia areata, and being evaluated in one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar’s pipeline also includes preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422.<\/p>\n

Nektar is headquartered in\u00a0San Francisco, California. For further information, visit\u00a0www.nektar.com<\/a>\u00a0and follow us on LinkedIn.<\/p>\n

\n Contacts<\/b>\n <\/p>\n

\n For Investors:<\/b>\n <\/p>\n

Vivian Wu
628-895-0661
VWu@nektar.com<\/a>\u00a0<\/p>\n

Corey Davis, Ph.D.
LifeSci Advisors
212-915-2577
cdavis@lifesciadvisors.com<\/a>\u00a0<\/p>\n

\n For Media:<\/b>\n <\/p>\n

Susan Roberts
LifeSci Communications
202-779-0929
sroberts@lifescicomms.com<\/a>\u00a0<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-us-based-financial-markets-302837015.html<\/a><\/p>\n

SOURCE Nektar Therapeutics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN FRANCISCO, July 28, 2026 \/PRNewswire\/ — Nektar\u00a0Therapeutics (Nasdaq:\u00a0NKTR) will announce its financial results for the second quarter ended June 30, 2026 on\u00a0Thursday, August 13, 2026, after the close of\u00a0U.S.-based financial markets.\u00a0Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at\u00a05:00 p.m. Eastern Time\/2:00 p.m. Pacific Time. This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar\u00a0website:\u00a0https:\/\/ir.nektar.com\/.\u00a0The web broadcast of the conference call will be available for replay through\u00a0September 13, 2026. To\u00a0access\u00a0the\u00a0conference\u00a0call,\u00a0please\u00a0pre-register\u00a0here. \u00a0All registrants will receive dial-in information and a PIN allowing them to access the live call. About\u00a0Nektar Therapeutics … <\/p>\n

Continue reading “Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-986095","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN FRANCISCO, July 28, 2026 \/PRNewswire\/ — Nektar\u00a0Therapeutics (Nasdaq:\u00a0NKTR) will announce its financial results for the second quarter ended June 30, 2026 on\u00a0Thursday, August 13, 2026, after the close of\u00a0U.S.-based financial markets.\u00a0Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at\u00a05:00 p.m. Eastern Time\/2:00 p.m. Pacific Time. This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar\u00a0website:\u00a0https:\/\/ir.nektar.com\/.\u00a0The web broadcast of the conference call will be available for replay through\u00a0September 13, 2026. To\u00a0access\u00a0the\u00a0conference\u00a0call,\u00a0please\u00a0pre-register\u00a0here. \u00a0All registrants will receive dial-in information and a PIN allowing them to access the live call. About\u00a0Nektar Therapeutics … Continue reading "Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-28T22:10:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets\",\"datePublished\":\"2026-07-28T22:10:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/\"},\"wordCount\":324,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS565268\\\/Nektar-Logo-v1.jpg?id=OA2798427\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/\",\"name\":\"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS565268\\\/Nektar-Logo-v1.jpg?id=OA2798427\",\"datePublished\":\"2026-07-28T22:10:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS565268\\\/Nektar-Logo-v1.jpg?id=OA2798427\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS565268\\\/Nektar-Logo-v1.jpg?id=OA2798427\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/","og_locale":"en_US","og_type":"article","og_title":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk","og_description":"PR Newswire SAN FRANCISCO, July 28, 2026 \/PRNewswire\/ — Nektar\u00a0Therapeutics (Nasdaq:\u00a0NKTR) will announce its financial results for the second quarter ended June 30, 2026 on\u00a0Thursday, August 13, 2026, after the close of\u00a0U.S.-based financial markets.\u00a0Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at\u00a05:00 p.m. Eastern Time\/2:00 p.m. Pacific Time. This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar\u00a0website:\u00a0https:\/\/ir.nektar.com\/.\u00a0The web broadcast of the conference call will be available for replay through\u00a0September 13, 2026. To\u00a0access\u00a0the\u00a0conference\u00a0call,\u00a0please\u00a0pre-register\u00a0here. \u00a0All registrants will receive dial-in information and a PIN allowing them to access the live call. About\u00a0Nektar Therapeutics … Continue reading \"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-28T22:10:54+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets","datePublished":"2026-07-28T22:10:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/"},"wordCount":324,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/","name":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427","datePublished":"2026-07-28T22:10:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS565268\/Nektar-Logo-v1.jpg?id=OA2798427"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nektar-therapeutics-to-announce-financial-results-for-the-second-quarter-on-thursday-august-13-2026-after-close-of-u-s-based-financial-markets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=986095"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/986095\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=986095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=986095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=986095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}